Interaction of Human Lactoferrin with Cell Adhesion Molecules through RGD Motif Elucidated by Lactoferrin-binding Epitopes*

Lactoferrin (LF) is an iron-binding secretory protein, which is distributed in the secondary granules of polynuclear lymphocytes as well as in the milk produced by female mammals. Although it has multiple functions, for example antimicrobial, immunomodulatory, antiviral, and anti-tumor metastasis activities, the receptors responsible for these activities are not fully understood. In this study, the binding epitopes for human LF were first isolated from a hexameric random peptide library displayed on T7 phage. Interestingly, two of the four isolated peptides had a representative cell adhesion motif, Arg-Gly-Asp (RGD), implying that human LF interacts with proteins with the RGD motif. We found that human LF bound to the RGD-containing human extracellular matrix proteins, fibronectin and vitronectin. Furthermore, human LF inhibited cell adhesion to these matrix proteins in a concentration-dependent manner but not to the RGD-independent cell adhesion molecule like laminin or collagen. These results indicate that a function of human LF is to block the various interactions between the cell surface and adhesion molecules. This may explain the multifunctionality of LF.

[1]  E. Burstein,et al.  Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. , 1998, The Journal of infectious diseases.

[2]  M. Chance,et al.  Structural reorganization of the transferrin C-lobe and transferrin receptor upon complex formation: the C-lobe binds to the receptor helical domain. , 2003, Biochemistry.

[3]  H. Koeffler,et al.  Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.

[4]  S. Kaneko,et al.  Hepatitis C virus envelope proteins bind lactoferrin , 1997, Journal of virology.

[5]  C. Joe,et al.  Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. , 2004, International immunopharmacology.

[6]  Y. Suzuki,et al.  Molecular cloning and functional expression of a human intestinal lactoferrin receptor. , 2001, Biochemistry.

[7]  Mathieu Carpentier,et al.  Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. , 2004, European journal of biochemistry.

[8]  H. Nomoto,et al.  Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. , 2004, Cytokine.

[9]  H. Ashino,et al.  Bovine lactoferrin inhibits tumor‐induced angiogenesis , 2004, International journal of cancer.

[10]  Jen-Ren Wang,et al.  Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. , 2005, Antiviral research.

[11]  Renhao Li,et al.  Use of phage display to probe the evolution of binding specificity and affinity in integrins. , 2003, Protein engineering.

[12]  A. Amoroso,et al.  Review: Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application , 2002, Journal of endotoxin research.

[13]  P. Newman,et al.  Integrin Activation by Regulated Dimerization and Oligomerization of Platelet Endothelial Cell Adhesion Molecule (Pecam)-1 from within the Cell , 2001, The Journal of cell biology.

[14]  I. Mattsby‐Baltzer,et al.  Orally administered bovine lactoferrin systemically inhibits VEGF165-mediated angiogenesis in the rat , 2001 .

[15]  H. Overkleeft,et al.  Solid-phase synthesis of cyclic RGD-furanoid sugar amino acid peptides as integrin inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[16]  V. Salmon,et al.  The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. , 1997, The Biochemical journal.

[17]  Thomas Walz,et al.  Structure of the Human Transferrin Receptor-Transferrin Complex , 2004, Cell.

[18]  L. Szekely,et al.  Endogenous fibronectin of blood polymorphonuclear leukocytes: immunochemical characterization and subcellular localization. , 1997, Experimental cell research.

[19]  G. Forni,et al.  Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy , 2004, International journal of cancer.

[20]  V. Salmon,et al.  Lactoferrin Inhibits the Endotoxin Interaction with CD14 by Competition with the Lipopolysaccharide-Binding Protein , 1998, Infection and Immunity.

[21]  M. Harmsen,et al.  Antiviral activities of lactoferrin. , 2001, Antiviral research.

[22]  S. Sugai,et al.  Analyses for binding of the transferrin family of proteins to the transferrin receptor 2 , 2004, British journal of haematology.

[23]  B. Ohlsson,et al.  Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB , 2002 .

[24]  P. V. van Berkel,et al.  N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. , 1997, The Biochemical journal.